Vedanta Biosciences logo

Vedanta Biosciences

A biotechnology company that develops medicines based on live bacterial consortia that can colonize the human intestine.

13

Funding Rounds

$386.6m

Money raised

Overview

A biotechnology company that develops medicines based on live bacterial consortia that can colonize the human intestine.

Funding

Funding series

Funding Series Analysis

The company Vedanta Biosciences has raised a total of $305.8m in funding over 13 rounds.

Key Insights:

  • Vedanta Biosciences Series D round, July 2021: $68m
  • Vedanta Biosciences Venture round, January 12, 2021: $25m
  • Vedanta Biosciences Grant (money), September 30, 2020: $76.9m
  • Vedanta Biosciences funding round, September 2019: $16.6m
  • Vedanta Biosciences Series C round, May 13, 2019: $18.5m
  • Vedanta Biosciences Series C round, December 24, 2018: $45.4m
  • Vedanta Biosciences Grant (money), November 3, 2017: $5.4m
  • Vedanta Biosciences Private equity, June 6, 2016: $50m
  • Vedanta Biosciences Grant (money), December 2019: $5.8m
  • VEDANTA BIOSCIENCES, INC. funding round, August 2021: $75m
Vedanta Biosciences logo
Vedanta Biosciences Series D round, July 2021 $68m
Vedanta Biosciences logo
Vedanta Biosciences Venture round, January 12, 2021 $25m
Vedanta Biosciences logo
Vedanta Biosciences Grant (money), September 30, 2020 $76.9m
Vedanta Biosciences logo
Vedanta Biosciences funding round, September 2019 $16.6m
Vedanta Biosciences logo
Vedanta Biosciences Series C round, May 13, 2019 $18.5m
Vedanta Biosciences logo
Vedanta Biosciences Series C round, December 24, 2018 $45.4m
Vedanta Biosciences logo
Vedanta Biosciences Grant (money), November 3, 2017 $5.4m
Vedanta Biosciences logo
Vedanta Biosciences Private equity, June 6, 2016 $50m
Vedanta Biosciences logo
Vedanta Biosciences Grant (money), December 2019 $5.8m
Vedanta Biosciences logo
VEDANTA BIOSCIENCES, INC. funding round, August 2021 $75m